Last reviewed · How we verify
YN001, Rosuvastatin calcium Tablets
YN001, Rosuvastatin calcium Tablets is a Small molecule drug developed by Beijing Inno Medicine Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | YN001, Rosuvastatin calcium Tablets |
|---|---|
| Sponsor | Beijing Inno Medicine Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase 1 Study of the Safety and Pharmacokinetics of YN001 With Rosuvastatin in Healthy Chinese Subjects (PHASE1)
- YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- YN001, Rosuvastatin calcium Tablets CI brief — competitive landscape report
- YN001, Rosuvastatin calcium Tablets updates RSS · CI watch RSS
- Beijing Inno Medicine Co., Ltd. portfolio CI
Frequently asked questions about YN001, Rosuvastatin calcium Tablets
What is YN001, Rosuvastatin calcium Tablets?
YN001, Rosuvastatin calcium Tablets is a Small molecule drug developed by Beijing Inno Medicine Co., Ltd..
Who makes YN001, Rosuvastatin calcium Tablets?
YN001, Rosuvastatin calcium Tablets is developed by Beijing Inno Medicine Co., Ltd. (see full Beijing Inno Medicine Co., Ltd. pipeline at /company/beijing-inno-medicine-co-ltd).
What development phase is YN001, Rosuvastatin calcium Tablets in?
YN001, Rosuvastatin calcium Tablets is in Phase 1.
Related
- Manufacturer: Beijing Inno Medicine Co., Ltd. — full pipeline